189 related articles for article (PubMed ID: 10571245)
1. Comparison of the efficacy of 7-hydroxystaurosporine (UCN-01) and other staurosporine analogs to abrogate cisplatin-induced cell cycle arrest in human breast cancer cell lines.
Lee SI; Brown MK; Eastman A
Biochem Pharmacol; 1999 Dec; 58(11):1713-21. PubMed ID: 10571245
[TBL] [Abstract][Full Text] [Related]
2. A novel indolocarbazole, ICP-1, abrogates DNA damage-induced cell cycle arrest and enhances cytotoxicity: similarities and differences to the cell cycle checkpoint abrogator UCN-01.
Eastman A; Kohn EA; Brown MK; Rathman J; Livingstone M; Blank DH; Gribble GW
Mol Cancer Ther; 2002 Oct; 1(12):1067-78. PubMed ID: 12481430
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of cisplatin-induced cytotoxicity by 7-hydroxystaurosporine (UCN-01), a new G2-checkpoint inhibitor.
Bunch RT; Eastman A
Clin Cancer Res; 1996 May; 2(5):791-7. PubMed ID: 9816232
[TBL] [Abstract][Full Text] [Related]
4. UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53.
Wang Q; Fan S; Eastman A; Worland PJ; Sausville EA; O'Connor PM
J Natl Cancer Inst; 1996 Jul; 88(14):956-65. PubMed ID: 8667426
[TBL] [Abstract][Full Text] [Related]
5. 7-Hydroxystaurosporine (UCN-01) causes redistribution of proliferating cell nuclear antigen and abrogates cisplatin-induced S-phase arrest in Chinese hamster ovary cells.
Bunch RT; Eastman A
Cell Growth Differ; 1997 Jul; 8(7):779-88. PubMed ID: 9218872
[TBL] [Abstract][Full Text] [Related]
6. UCN-01 selectively enhances mitomycin C cytotoxicity in p53 defective cells which is mediated through S and/or G(2) checkpoint abrogation.
Sugiyama K; Shimizu M; Akiyama T; Tamaoki T; Yamaguchi K; Takahashi R; Eastman A; Akinaga S
Int J Cancer; 2000 Mar; 85(5):703-9. PubMed ID: 10699952
[TBL] [Abstract][Full Text] [Related]
7. Implications of p53 in growth arrest and apoptosis on combined treatment of human Mammary epithelial cells with topotecan and UCN-01.
Redkar A; Mixter P; Daoud SS
J Exp Ther Oncol; 2004 Oct; 4(3):213-22. PubMed ID: 15724841
[TBL] [Abstract][Full Text] [Related]
8. Cell cycle-dependent potentiation of cisplatin by UCN-01 in non-small-cell lung carcinoma.
Mack PC; Gandara DR; Lau AH; Lara PN; Edelman MJ; Gumerlock PH
Cancer Chemother Pharmacol; 2003 Apr; 51(4):337-48. PubMed ID: 12721762
[TBL] [Abstract][Full Text] [Related]
9. Defective p53 signaling in p53 wild-type tumors attenuates p21waf1 induction and cyclin B repression rendering them sensitive to Chk1 inhibitors that abrogate DNA damage-induced S and G2 arrest.
Levesque AA; Fanous AA; Poh A; Eastman A
Mol Cancer Ther; 2008 Feb; 7(2):252-62. PubMed ID: 18281511
[TBL] [Abstract][Full Text] [Related]
10. Abrogation of the S phase DNA damage checkpoint results in S phase progression or premature mitosis depending on the concentration of 7-hydroxystaurosporine and the kinetics of Cdc25C activation.
Kohn EA; Ruth ND; Brown MK; Livingstone M; Eastman A
J Biol Chem; 2002 Jul; 277(29):26553-64. PubMed ID: 11953432
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of camptothecin-induced cytotoxicity with UCN-01 in breast cancer cells: abrogation of S/G(2) arrest.
Jones CB; Clements MK; Wasi S; Daoud SS
Cancer Chemother Pharmacol; 2000; 45(3):252-8. PubMed ID: 10663644
[TBL] [Abstract][Full Text] [Related]
12. UCN-01-mediated G1 arrest in normal but not tumor breast cells is pRb-dependent and p53-independent.
Chen X; Lowe M; Keyomarsi K
Oncogene; 1999 Oct; 18(41):5691-702. PubMed ID: 10577141
[TBL] [Abstract][Full Text] [Related]
13. Abrogation of an S-phase checkpoint and potentiation of camptothecin cytotoxicity by 7-hydroxystaurosporine (UCN-01) in human cancer cell lines, possibly influenced by p53 function.
Shao RG; Cao CX; Shimizu T; O'Connor PM; Kohn KW; Pommier Y
Cancer Res; 1997 Sep; 57(18):4029-35. PubMed ID: 9307289
[TBL] [Abstract][Full Text] [Related]
14. Influence of G2 arrest on the cytotoxicity of DNA topoisomerase inhibitors toward human carcinoma cells with different p53 status.
Bozko P; Larsen AK; Raymond E; Skladanowski A
Acta Biochim Pol; 2002; 49(1):109-19. PubMed ID: 12136930
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of UCN-01, staurosporine and CGP 41 251 on cell cycle progression and CDC2/cyclin B1 regulation in A431 cells synchronized at M phase by nocodazole.
Akiyama T; Shimizu M; Okabe M; Tamaoki T; Akinaga S
Anticancer Drugs; 1999 Jan; 10(1):67-78. PubMed ID: 10194549
[TBL] [Abstract][Full Text] [Related]
16. 7-hydroxystaurosporine (UCN-01) and ionizing radiation combine to inhibit the growth of Bcl-2-overexpressing U937 leukemia cells through a non-apoptotic mechanism.
Cartee L; Sankala H; Davis C; Smith R; Maggio S; Lin PS; Dent P; Grant S
Int J Oncol; 2002 Aug; 21(2):351-9. PubMed ID: 12118331
[TBL] [Abstract][Full Text] [Related]
17. Distinct roles for p53 transactivation and repression in preventing UCN-01-mediated abrogation of DNA damage-induced arrest at S and G2 cell cycle checkpoints.
Levesque AA; Kohn EA; Bresnick E; Eastman A
Oncogene; 2005 May; 24(23):3786-96. PubMed ID: 15782134
[TBL] [Abstract][Full Text] [Related]
18. Abrogation of the radiation-induced G2 checkpoint by the staurosporine derivative UCN-01 is associated with radiosensitisation in a subset of colorectal tumour cell lines.
Playle LC; Hicks DJ; Qualtrough D; Paraskeva C
Br J Cancer; 2002 Jul; 87(3):352-8. PubMed ID: 12177808
[TBL] [Abstract][Full Text] [Related]
19. RB status as a determinant of response to UCN-01 in non-small cell lung carcinoma.
Mack PC; Gandara DR; Bowen C; Edelman MJ; Paglieroni T; Schnier JB; Gelmann EP; Gumerlock PH
Clin Cancer Res; 1999 Sep; 5(9):2596-604. PubMed ID: 10499638
[TBL] [Abstract][Full Text] [Related]
20. UCN-01 induces S and G2/M cell cycle arrest through the p53/p21(waf1) or CHK2/CDC25C pathways and can suppress invasion in human hepatoma cell lines.
Wu G; Lin N; Xu L; Liu B; Feitelson MA
BMC Cancer; 2013 Mar; 13():167. PubMed ID: 23537372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
